Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000203095 | SCV000258117 | uncertain significance | not specified | 2014-12-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000725357 | SCV000336285 | uncertain significance | not provided | 2015-10-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001215638 | SCV001387392 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-08-21 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with asparagine, which is neutral and polar, at codon 271 of the MKS1 protein (p.His271Asn). This variant is present in population databases (rs201771125, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with MKS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 218743). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MKS1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV003227714 | SCV003925425 | uncertain significance | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2022-02-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530213 | SCV004718338 | uncertain significance | MKS1-related disorder | 2024-01-18 | criteria provided, single submitter | clinical testing | The MKS1 c.811C>A variant is predicted to result in the amino acid substitution p.His271Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.029% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004020498 | SCV004974248 | uncertain significance | Inborn genetic diseases | 2023-09-20 | criteria provided, single submitter | clinical testing | The c.811C>A (p.H271N) alteration is located in exon 8 (coding exon 8) of the MKS1 gene. This alteration results from a C to A substitution at nucleotide position 811, causing the histidine (H) at amino acid position 271 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001828042 | SCV002087648 | uncertain significance | Meckel syndrome, type 1 | 2020-02-12 | no assertion criteria provided | clinical testing |